Sol Atriyal Appendiks ve Nörohormonal Etkileri

Shanmugam N, Boerdlein A, Proff J, et al. Characterization of left atrial appendage anatomy in patients with atrial fibrillation and correlation with clinical variables using 3D cardiac computed tomography. Circ Arrhythm Electrophysiol. 2012;5(4):771-778.

Lip GY, Fauchier L, Freedman SB, et al. Atrial fibrillation. Nat Rev Dis Primers. 2016;2:16016.

Shinohara T, Park HW, Saito T, et al. Significance of sympathetic activation in the left atrial appendage and its association with atrial fibrillation. Circ J. 2019;83(9):1919-1927.

Zhang Y, Li C, Chen G, et al. Involvement of renin-angiotensin-aldosterone system in atrial fibrosis and the anti-fibrotic effect of valsartan in a goat atrial fibrillation model. Exp Ther Med. 2018;16(2):1109-1116.

Bartus K, Podolec P, Wilczek K, et al. Intracardiac echocardiography-guided left atrial appendage occlusion with Amplatzer Cardiac Plug: early experience. J Am Soc Echocardiogr. 2011;24(8):928-933.

Thakkar J, Leonelli F, Costopoulos C, et al. Left atrial appendage function and its potential role in cardiovascular pathophysiology. Eur Heart J Cardiovasc Imaging. 2020;21(4):357-367.

Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531-538.

Shanmugam N, Boerdlein A, Proff J, et al. Characterization of left atrial appendage anatomy in patients with atrial fibrillation and implications for left atrial appendage occlusion. J Am Coll Cardiol. 2017;69(7):855-867.

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14.

Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120-129.

Goette A, Lendeckel U, Kuchenbecker A, et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart. 2007;93(9):1056-1063.

Jons C, Joergensen RM, Hassager C, et al. Neurohormonal modulation for the treatment of cardiac disease: the quest for new targets. Heart Fail Rev. 2010;15(5):399-411.

Shinohara T, Park HW, Saito T, et al. Significance of sympathetic activation in the left atrial appendage and its association with atrial fibrillation. Circ J. 2019;83(9):1919-1927.

Linz D, Mahfoud F, Schotten U, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172-178.

Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344(14):1043-1051.

Kotecha D, Holmes J, Krum H, et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014;384(9961):2235-2243.

Pokushalov E, Kozlov B, Romanov A, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: three-year follow-up of a randomized study. Heart Rhythm. 2010;7(9):1257-1265.

Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1-12.

Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 1996;7(10):999-1007.

Herring N, Paterson DJ. Sympathetic control of the heart: role of noradrenaline cotransmission. Acta Physiol (Oxf). 2011;203(1):1-15.

Pokushalov E, Romanov A, Shugayev P, et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6(9):1257-1264.

Pachon JC, Pachon EI, Pachon JC, et al. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional sinus node dysfunction and hypertensive syndromes. Rev Esp Cardiol. 2011;64(11):1000-1020.

Pokushalov E, Kozlov B, Romanov A, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: three-year follow-up of a randomized study. Heart Rhythm. 2010;7(9):1257-1265.

Şabanoğlu C, Okutucu S, Halil İnanç I, et al. The impact of percutaneous left atrial appendage closure on left ventricular diastolic function and natriuretic peptide levels. Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7418-7424. doi: 10.26355/eurrev_202112_27439.

Krisai P, Belley-Cote EP, McIntyre WF, et al; on behalf of the LAAOS III Investigators. Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial. Eur J Heart Fail. 2025 Feb;27(2):285-292. doi: 10.1002/ejhf.3536.

Kotecha D, Holmes J, Krum H, et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014;384(9961):2235-2243.

Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 1997;96(9):3112-3115.

Veinot JP, Gattinger DA, Fliss H, et al. Characterization of left atrial appendage trabeculations using 3D cardiac CT. J Cardiovasc Electrophysiol. 2013;24(11):1258-1264.

Shanmugam N, Tamboli MA, Bhosale G, et al. Association of left atrial appendage morphology and stroke in patients with atrial fibrillation: a 3D cardiac computed tomographic study. JACC Cardiovasc Imaging. 2017;10(4):487-495.

Leong DP, Chiu CZ, McNamara RL, et al. Provisional 2018 Nomenclature and Classification of the Left Atrial Appendage. Circ Cardiovasc Interv. 2018;11(10):e007395.